Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants

This publication has 33 references indexed in Scilit:

• Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes
  The Lancet Diabetes & Endocrinology, 2023
• Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes
  JAMA, 2023
• A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
  The Lancet, 2019
• Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles
  JACC, 2019
• Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines
  Primary Care Diabetes, 2019
• Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors
  Nutrition & Diabetes, 2018
• Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial
  The Lancet, 2018
• Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
  The Lancet, 2011
• 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
  New England Journal of Medicine, 2008
• Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
  The Lancet, 1999